Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Open-angle Glaucoma and Ocular Hypertension”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06355765
What this trial is testing

Citicoline & Antioxidants in Glaucoma

Who this might be right for
Glaucoma, Open-Angle
University of Naples 60
Not applicableStudy completedNCT01769521
What this trial is testing

Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG

Who this might be right for
Primary Open Angle GlaucomaNormal Tension Glaucoma
Sensimed AG 20
Not applicableStudy completedNCT04828057
What this trial is testing

Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting

Who this might be right for
Ocular Surface DiseasePrimary Open Angle Glaucoma
Santen Pharmaceutical (Taiwan) Co., LTD 50
Large-scale testing (Phase 3)Study completedNCT01217606
What this trial is testing

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 185
Post-approval studies (Phase 4)Study completedNCT00330577
What this trial is testing

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Aristotle University Of Thessaloniki 30
Not applicableLooking for participantsNCT07599241
What this trial is testing

Additive Efficacy of Physical Activity Program in Hypthyroidism Elder Females With Glaucoma and Fatty Liver Issues

Who this might be right for
Subclinical hypothyroïdismNon-Alcoholic Fatty Liver DiseasePrimary Open Angle Glaucoma
Cairo University 40
Not applicableStudy completedNCT01881425
What this trial is testing

InnFocus MicroShunt Versus Trabeculectomy Study

Who this might be right for
Primary Open Angle Glaucoma
InnFocus Inc. 732
Testing effectiveness (Phase 2)Study completedNCT02371746
What this trial is testing

Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma

Who this might be right for
Glaucoma and Ocular Hypertension
Envisia Therapeutics 41
Testing effectiveness (Phase 2)UnknownNCT01520116
What this trial is testing

Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Altheos, Inc. 180
Not applicableStudy completedNCT01252849
What this trial is testing

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Who this might be right for
Primary Open Angle Glaucoma (POAG)
Glaukos Corporation 119
Not applicableStudy completedNCT04461249
What this trial is testing

Comparison Between Latanoprost , Travoprost and Tafluprost in Reducing IOP Fluctuation in POAG Patients

Who this might be right for
Primary Open Angle Glaucoma
Kasr El Aini Hospital 60
Not applicableWithdrawnNCT01766947
What this trial is testing

IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy

Who this might be right for
Primary Open Angle Glaucoma
Sensimed AG
Not applicableStudy completedNCT03541551
What this trial is testing

Ologen® Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy

Who this might be right for
Primary Congenital GlaucomaDevelopmental GlaucomaInfantile Glaucoma
L.V. Prasad Eye Institute 44
Testing effectiveness (Phase 2)Study completedNCT03216902
What this trial is testing

A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study

Who this might be right for
Open-angle Glaucoma, Ocular Hypertension
Santen Inc. 241
Post-approval studies (Phase 4)UnknownNCT02792803
What this trial is testing

A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma

Who this might be right for
POAGPrimary Open Angle GlaucomaOcular Hypertension
Dr. David Yan 60
Not applicableUnknownNCT04709497
What this trial is testing

Surgery for Primary Congenital Glaucoma in Neonates

Who this might be right for
Primary Congenital Glaucoma
Mansoura University 60
Not applicableStudy completedNCT05104294
What this trial is testing

Correlation Between Optical Coherence Tomography Angiography and Photopic Negative Response in Patients With Glaucoma

Who this might be right for
Open Angle Glaucoma
Benha University 76
Not applicableStudy completedNCT02177123
What this trial is testing

Post Market Study of the InnFocus MicroShunt

Who this might be right for
Primary Open Angle Glaucoma
InnFocus Inc. 107
Testing effectiveness (Phase 2)Study completedNCT06144918
What this trial is testing

Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye Pressure

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Skye Bioscience, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT00868894
What this trial is testing

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Santen Inc. 49
Next Page